• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BPO
Click for more information
0.00% 0.3¢

BIOPROSPECT LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BPORe Gen Wellness Products newsletter08/06/11
BPONotice of Extraordinary General Meeting/Proxy Form02/06/11
BPOBPO and Frontier extend exclusivity periodPRICE SENSITIVE12/05/11
BPOAppendix 4C - quarterlyPRICE SENSITIVE29/04/11
BPOCompletion of due diligence on Frontier GasfieldsPRICE SENSITIVE19/04/11
BPOMarch issue of Bionews05/04/11
BPOUpdate on Frontier Gasfields Pty Ltd due diligencePRICE SENSITIVE31/03/11
BPOUpdate on Frontier Gasfields due diligencePRICE SENSITIVE10/03/11
BPOTrading HaltPRICE SENSITIVE08/03/11
AAX +Change of Share Registry Address07/03/11
BPOASX response to BPO announcement 3 MarchPRICE SENSITIVE07/03/11
BPO +Comments on release concerning Philippine Service Contracts03/03/11
BPOTrading HaltPRICE SENSITIVE03/03/11
BPONew investment into Oil and Gas assetsPRICE SENSITIVE03/03/11
BPOTrading HaltPRICE SENSITIVE02/03/11
BPOHalf Yearly Report and AccountsPRICE SENSITIVE25/02/11
BPOReplacement for App 3X lodged 22 Feb 11 J Khouri24/02/11
BPOInitial Director's Interest Notice22/02/11
BPOGI-GUARD Oral paste in horses -Development UpdatePRICE SENSITIVE17/02/11
BPODirector Appointment/Resignation16/02/11
BPOPlacement and Appendix 3BPRICE SENSITIVE16/02/11
BPODistribution agreement for REGEN productsPRICE SENSITIVE15/02/11
BPOAppendix 4C - quarterlyPRICE SENSITIVE28/01/11
BPOAppendix 3B19/01/11
BPOREGEN business updatePRICE SENSITIVE23/12/10
BPO +GI-GUARD Oral Paste -APVMA update21/12/10
BPOResponse to ASX Appendix 3Y Query16/12/10
BPOTop 20 securityholders14/12/10
BPOChange of Director's Interest Notice14/12/10
BPOAppendix 3B13/12/10
BPOAppendix 3B Final Rights Issue07/12/10
BPOChange of Director's Interest Notice03/12/10
BPORights Issue uptake01/12/10
BPOResults of Meeting30/11/10
BPOAGM Presentation 201029/11/10
BPO +Response to Solagran's AGM presentation26/11/10
BPOProspectus dispatched to shareholdersPRICE SENSITIVE10/11/10
BPOSupplementary Prospectus dispatched to shareholders10/11/10
BPO +Settlement of Legal Dispute with BPOPRICE SENSITIVE04/11/10
BPO +Ceasing to be a substantial holder from SLA02/11/10
BPOSupplementary Prospectus01/11/10
BPOAppendix 4C - quarterlyPRICE SENSITIVE29/10/10
BPO +Update on Legal dispute with Solagran LimitedPRICE SENSITIVE27/10/10
BPONotice of Annual General Meeting/Proxy Form27/10/10
BPOAnnual Report to shareholders27/10/10
BPOProspectus Clarification26/10/10
BPOLetter to shareholders and option holders for Rights Issue26/10/10
BPORights Issue ProspectusPRICE SENSITIVE26/10/10
BPONon Renounceable Rights Issue and Appendix 3B26/10/10
BPOTermilone Project UpdatePRICE SENSITIVE22/10/10
BPORights Issue Announcement amendment19/10/10
BPOShare Placement, Appendix 3B and Righst IssuePRICE SENSITIVE19/10/10
BPOOctober issue of Bionews12/10/10
BPO +Solagran Successful in Federal Court04/10/10
BPOExpiry of Director Options01/10/10
BPOResponse to ASX Query re Appendix 3Y29/09/10
BPOFull Year Statutory Accounts28/09/10
BPO +Update on Federal court proceedings with Solagran28/09/10
BPOChange of Director's Interest Notice23/09/10
BPOBioProspect secures alternative CGNC supplyPRICE SENSITIVE20/09/10
BPOResignation of Director / Appendix 3Z17/09/10
BPO +Update on dispute with Solagran16/09/10
BPO +Legal Proceedings Commenced By BioProspect Limited09/09/10
BPO +Dispute with Solagran LimitedPRICE SENSITIVE06/09/10
BPOPreliminary Final ReportPRICE SENSITIVE31/08/10
BPO +Update on dispute with Solagran LimtedPRICE SENSITIVE13/08/10
BPO +Notice of Dispute with BioProspect05/08/10
BPO +Dispute with Solagran Limited03/08/10
BPOAppendix 4C - quarterlyPRICE SENSITIVE30/07/10
BPO +Dispute with Solagran Limited29/07/10
BPO +Development Agreement with Solagran Ltd08/07/10
BPOTermilone trials updatePRICE SENSITIVE30/06/10
BPO +Solagran and BioProspect Development Agreement29/06/10
BPODirector Appointment/Resignation29/06/10
BPO +Bioeffectives Project with BioProspect LimitedPRICE SENSITIVE28/06/10
BPOTrading HaltPRICE SENSITIVE25/06/10
BPOChange of Director's Interest Notice21/06/10
BPO2010 SPP results and Appendix 3B18/06/10
BPOGI-GUARD horse treatment submitted for regulatory approvalPRICE SENSITIVE11/06/10
BPOResults of Meeting04/06/10
BPOGeneral Meeting Presentation 3rd June04/06/10
BPOGeneral Meeting Presentation June 201003/06/10
BPOAGRIPRO natural animal health products updatePRICE SENSITIVE31/05/10
BPOUpdate on Re Gen Wellness productsPRICE SENSITIVE25/05/10
BPOShare Purchase Plan - Extension to closing date.25/05/10
BPOTermilone commercialisation updatePRICE SENSITIVE21/05/10
BPO2010 Share Purchase Plan -Issue price and termsPRICE SENSITIVE12/05/10
BPOShare Purchase Plan clarification04/05/10
BPOShare Placement and Appendix 3BPRICE SENSITIVE30/04/10
BPONotice of General Meeting/Proxy Form30/04/10
BPOAnnouncement of Share Purchase PlanPRICE SENSITIVE30/04/10
BPOAppendix 4C - quarterlyPRICE SENSITIVE29/04/10
BPOTermilone CSIRO Field Trial resultsPRICE SENSITIVE23/04/10
BPOResponse to ASX Query - Expiry of Options16/04/10
BPOExpiry of Listed Options BPOOB31/03/10
BPOMarch 2010 issue of Bionews31/03/10
BPOBioProspect announces successful horse safety studiesPRICE SENSITIVE30/03/10
BPO +Change in substantial holding from SLA15/03/10
BPOAppendix 3B05/03/10
BPOHalf Yearly Report and AccountsPRICE SENSITIVE25/02/10
BPORe Gen Wellness Products newsletter
08/06/11
BPONotice of Extraordinary General Meeting/Proxy Form
02/06/11
BPOBPO and Frontier extend exclusivity period
12/05/11PRICE SENSITIVE
BPOAppendix 4C - quarterly
29/04/11PRICE SENSITIVE
BPOCompletion of due diligence on Frontier Gasfields
19/04/11PRICE SENSITIVE
BPOMarch issue of Bionews
05/04/11
BPOUpdate on Frontier Gasfields Pty Ltd due diligence
31/03/11PRICE SENSITIVE
BPOUpdate on Frontier Gasfields due diligence
10/03/11PRICE SENSITIVE
BPOTrading Halt
08/03/11PRICE SENSITIVE
AAX +Change of Share Registry Address
07/03/11
BPOASX response to BPO announcement 3 March
07/03/11PRICE SENSITIVE
BPO +Comments on release concerning Philippine Service Contracts
03/03/11
BPOTrading Halt
03/03/11PRICE SENSITIVE
BPONew investment into Oil and Gas assets
03/03/11PRICE SENSITIVE
BPOTrading Halt
02/03/11PRICE SENSITIVE
BPOHalf Yearly Report and Accounts
25/02/11PRICE SENSITIVE
BPOReplacement for App 3X lodged 22 Feb 11 J Khouri
24/02/11
BPOInitial Director's Interest Notice
22/02/11
BPOGI-GUARD Oral paste in horses -Development Update
17/02/11PRICE SENSITIVE
BPODirector Appointment/Resignation
16/02/11
BPOPlacement and Appendix 3B
16/02/11PRICE SENSITIVE
BPODistribution agreement for REGEN products
15/02/11PRICE SENSITIVE
BPOAppendix 4C - quarterly
28/01/11PRICE SENSITIVE
BPOAppendix 3B
19/01/11
BPOREGEN business update
23/12/10PRICE SENSITIVE
BPO +GI-GUARD Oral Paste -APVMA update
21/12/10
BPOResponse to ASX Appendix 3Y Query
16/12/10
BPOTop 20 securityholders
14/12/10
BPOChange of Director's Interest Notice
14/12/10
BPOAppendix 3B
13/12/10
BPOAppendix 3B Final Rights Issue
07/12/10
BPOChange of Director's Interest Notice
03/12/10
BPORights Issue uptake
01/12/10
BPOResults of Meeting
30/11/10
BPOAGM Presentation 2010
29/11/10
BPO +Response to Solagran's AGM presentation
26/11/10
BPOProspectus dispatched to shareholders
10/11/10PRICE SENSITIVE
BPOSupplementary Prospectus dispatched to shareholders
10/11/10
BPO +Settlement of Legal Dispute with BPO
04/11/10PRICE SENSITIVE
BPO +Ceasing to be a substantial holder from SLA
02/11/10
BPOSupplementary Prospectus
01/11/10
BPOAppendix 4C - quarterly
29/10/10PRICE SENSITIVE
BPO +Update on Legal dispute with Solagran Limited
27/10/10PRICE SENSITIVE
BPONotice of Annual General Meeting/Proxy Form
27/10/10
BPOAnnual Report to shareholders
27/10/10
BPOProspectus Clarification
26/10/10
BPOLetter to shareholders and option holders for Rights Issue
26/10/10
BPORights Issue Prospectus
26/10/10PRICE SENSITIVE
BPONon Renounceable Rights Issue and Appendix 3B
26/10/10
BPOTermilone Project Update
22/10/10PRICE SENSITIVE
BPORights Issue Announcement amendment
19/10/10
BPOShare Placement, Appendix 3B and Righst Issue
19/10/10PRICE SENSITIVE
BPOOctober issue of Bionews
12/10/10
BPO +Solagran Successful in Federal Court
04/10/10
BPOExpiry of Director Options
01/10/10
BPOResponse to ASX Query re Appendix 3Y
29/09/10
BPOFull Year Statutory Accounts
28/09/10
BPO +Update on Federal court proceedings with Solagran
28/09/10
BPOChange of Director's Interest Notice
23/09/10
BPOBioProspect secures alternative CGNC supply
20/09/10PRICE SENSITIVE
BPOResignation of Director / Appendix 3Z
17/09/10
BPO +Update on dispute with Solagran
16/09/10
BPO +Legal Proceedings Commenced By BioProspect Limited
09/09/10
BPO +Dispute with Solagran Limited
06/09/10PRICE SENSITIVE
BPOPreliminary Final Report
31/08/10PRICE SENSITIVE
BPO +Update on dispute with Solagran Limted
13/08/10PRICE SENSITIVE
BPO +Notice of Dispute with BioProspect
05/08/10
BPO +Dispute with Solagran Limited
03/08/10
BPOAppendix 4C - quarterly
30/07/10PRICE SENSITIVE
BPO +Dispute with Solagran Limited
29/07/10
BPO +Development Agreement with Solagran Ltd
08/07/10
BPOTermilone trials update
30/06/10PRICE SENSITIVE
BPO +Solagran and BioProspect Development Agreement
29/06/10
BPODirector Appointment/Resignation
29/06/10
BPO +Bioeffectives Project with BioProspect Limited
28/06/10PRICE SENSITIVE
BPOTrading Halt
25/06/10PRICE SENSITIVE
BPOChange of Director's Interest Notice
21/06/10
BPO2010 SPP results and Appendix 3B
18/06/10
BPOGI-GUARD horse treatment submitted for regulatory approval
11/06/10PRICE SENSITIVE
BPOResults of Meeting
04/06/10
BPOGeneral Meeting Presentation 3rd June
04/06/10
BPOGeneral Meeting Presentation June 2010
03/06/10
BPOAGRIPRO natural animal health products update
31/05/10PRICE SENSITIVE
BPOUpdate on Re Gen Wellness products
25/05/10PRICE SENSITIVE
BPOShare Purchase Plan - Extension to closing date.
25/05/10
BPOTermilone commercialisation update
21/05/10PRICE SENSITIVE
BPO2010 Share Purchase Plan -Issue price and terms
12/05/10PRICE SENSITIVE
BPOShare Purchase Plan clarification
04/05/10
BPOShare Placement and Appendix 3B
30/04/10PRICE SENSITIVE
BPONotice of General Meeting/Proxy Form
30/04/10
BPOAnnouncement of Share Purchase Plan
30/04/10PRICE SENSITIVE
BPOAppendix 4C - quarterly
29/04/10PRICE SENSITIVE
BPOTermilone CSIRO Field Trial results
23/04/10PRICE SENSITIVE
BPOResponse to ASX Query - Expiry of Options
16/04/10
BPOExpiry of Listed Options BPOOB
31/03/10
BPOMarch 2010 issue of Bionews
31/03/10
BPOBioProspect announces successful horse safety studies
30/03/10PRICE SENSITIVE
BPO +Change in substantial holding from SLA
15/03/10
BPOAppendix 3B
05/03/10
BPOHalf Yearly Report and Accounts
25/02/10PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024 The ASX 200 is tipped to rise as much as 1% at open today after Wall Street enjoyed another major @Trump trade” surge buoyed by year-end optimism.The Dow Jones leaped 1.06% amid the U.S. jump, with the S@P 500 following close behind with a 0.53% rise @ a trend the Aussie bou...
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Asian Battery Metals uncover second massive sulphide discovery at Mongolia's Oval play Asian Battery Metals Plc has hit another massive sulphide intercept at the North Oval area of its Oval project in Mongolia
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.